Rational Vaccines

Rational Vaccines

  • Founded: 2015
  • Location: Woburn, MA
  • Employee range: 1 - 10
  • Clinical stage: Clin0
  • Therapy area: HSV-2 treatment
  • Drug types: INF, VAC
  • Lead product: RVx-201
  • Product link: https://rationalvaccines.com/science/



Short description:

Herpes Vaccine

Drug notes:

RVx-2001 Clin0 HSV-2 prevention; RVx-1001 Clin0 HSV-1 prevention

Long description:

Rational Vaccines is researching infectious diseases to improve the treatment, prevention and diagnosis of herpes worldwide. Smallpox virus was successfully eradicated through the use of a live-attenuated vaccine. Now, Rational Vaccines is applying the science of attenuating live viruses to develop an entirely new class of therapeutic and prophylactic herpes treatments. Rational Vaccines proprietary vaccine candidates carry attenuating mutations in a key viral gene that encodes the protein ICPO which controls the balance between herpes latency and replication - their lead candidate, RVx-201, has shown positive antibody responses in preclinical studies.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com